. Comparative Value of Cholinesterase Inhibitors and Memantine in Persons with Moderate-to-Severe Alzheimer's Disease in the United States: A Cost-Effectiveness Analysis. J Alzheimers Dis Rep. 2021;5(1):705-713. Epub 2021 Sep 6 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Aduhelm Lowers Tau; Registry to Track Real-World Performance